Lyme Disease Diagnostic Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Lyme Disease Diagnostic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Lyme Disease Diagnostic Devices market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Serological Test
Urine Antigen Tests
Lymphocytic Transformation Test
Immunofluorescent Staining
Nucleic Acid Test

Segment by Application
Hospitals
Public/Private Laboratories
Physician’s Office

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Abbott Laboratories
T2 Biosystems, Inc.
Bio-Rad Laboratories
Alere Inc.
Roche Diagnostics
Covance Inc.
Immunetics, Inc.
GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd)
Oxford Immunotec Global PLC(Boulder Diagnostics Inc.)
Thermo Fisher Scientific(Affymetrix)
Siemens AG
Baxter International Inc.
Fresenius Medical Care AG & Co.